Immuneering Corp (IMRX)

2.20 -0.05 (-2.22%) USD  |  NASDAQ  |  Dec 31, 16:00
2.22 +0.02 (+0.91%) After-Hours: 20:00
More

Immuneering Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for IMRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Quarter Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
Amicus Therapeutics Inc Upgrade
PTC Therapeutics Inc Upgrade
Aadi Bioscience Inc Upgrade
AN2 Therapeutics Inc Upgrade
NovaBay Pharmaceuticals Inc Upgrade

Revenue Estimates for Current Quarter Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade